B

Biohaven Ltd
D

BHVN

35.750
USD
-0.52
(-1.43%)
مفتوح الان
حجم التداول
4,420
الربح لكل سهم
-9
العائد الربحي
-
P/E
-4
حجم السوق
3,609,052,960
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.090
    (-0.53%)
    16.790 USD
    A
    AGIO
    -0.410
    (-1.16%)
    34.980 USD
    A
    ALKS
    -0.390
    (-1.31%)
    29.360 USD
    A
    ALLO
    0.01000
    (0.53%)
    1.88000 USD
    B
    BPMC
    -0.720
    (-0.80%)
    89.400 USD
    C
    CRSP
    -0.720
    (-1.77%)
    40.000 USD
    I
    ICPT
    0.000000
    (0.00%)
    0.000000 USD
    R
    RGNX
    -0.25000
    (-3.28%)
    7.38000 USD
    S
    SRPT
    -0.500
    (-0.42%)
    118.470 USD
    VRTX
    VRTX
    -0.73
    (-0.18%)
    397.59 USD
    المزيد
الأخبار

العنوان: Biohaven Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.